About Enhancer

Enhancer ID: E_01_0219
Species: human
Position : chr12:6531600-6533600
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  31621893
Enhancer experiment: PCR, Western blot, immunofluorescence staining
Enhancer experiment description: The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .

About Target gene

Target gene : Gapdh
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .;The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .

About TF

TF name : GAPDH
TF experiment: PCR,Western blot,??????
TF experiment description: The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .;The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .

About Function

Enhancer function : The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
The GAPDH/Gapdh served as an internal control for mRNA expression. The fold change in target mRNA expression was calculated using the equation 2???Ct .

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number
GAPDH AndrogenReceptor netpath 167
GAPDH Fanconi-bickel syndrome smpdb 14
GAPDH Fructose-1,6-diphosphatase deficiency smpdb 22
GAPDH gluconeogenesis humancyc 24
GAPDH Gluconeogenesis reactome 32
GAPDH Gluconeogenesis smpdb 22
GAPDH Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease smpdb 22
GAPDH Glycogenosis, Type IA. Von gierke disease smpdb 22
GAPDH Glycogenosis, Type IB smpdb 22
GAPDH Glycogenosis, Type IC smpdb 22
GAPDH Glycogenosis, Type VII. Tarui disease smpdb 14
GAPDH glycolysis humancyc 24
GAPDH Glycolysis panther 17
GAPDH Glycolysis reactome 32
GAPDH Glycolysis smpdb 14
GAPDH Huntington disease panther 113
GAPDH Mitochondrial Electron Transport Chain smpdb 8
GAPDH Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1) smpdb 22
GAPDH superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle humancyc 46
GAPDH Triosephosphate isomerase smpdb 22
GAPDH Validated targets of C-MYC transcriptional activation pid 80
GAPDH Warburg Effect smpdb 45
GAPDH Glycolysis / Gluconeogenesis kegg 64
GAPDH Alzheimer's disease kegg 167
GAPDH Hs_Alzheimers_Disease_WP2059_87372 wikipathways 24

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs